Clinical Trials Logo

Reduction of Initial AHI by =20% clinical trials

View clinical trials related to Reduction of Initial AHI by =20%.

Filter by:
  • None
  • Page 1

NCT ID: NCT02094482 Recruiting - Clinical trials for Reduction of Initial Snoaring Index by =30%.

Prospective Evaluation of a New Palatal Implant for Treatment of Snoring and Obstructive Sleep Apnea (OSAS)

Start date: April 2014
Phase: N/A
Study type: Interventional

The new OSAS Implant is intended for use in the palate (hard and soft palate/ see picture above) in order to stiffen and stabilize the soft palate, which may reduce the severity of airway obstructions and of snoring in patients suffering from OSA (Obstructive Sleep Apnea). Indications for use of the System include: symptomatic, habitual, social snoring due to palatal flutter or upper airway obstruction primarily caused by the retropalatal obstruction. The System is labeled for use by physicians only. The primary endpoint is the Apnea-Hypopnea-Index (AHI) in the 90 days follow-up. Study hypothesis: Reduction of initial AHI ≥20%